What is Upstream Bio, Inc.?
, a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 152.38M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.